ArticleBMC gastroenterology2026

GCKR genetic variants and circulating FGF21 identify a metabolic risk signature in metabolic dysfunction-associated steatotic liver disease.

Asmaa Mohamed Fteah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.